Related Experiment Videos
Multiple primary malignancies in a renal transplant patient
E Barroso-Vicens1, G Ramirez, H Rabb
1Division of Nephrology and Hypertension, Department of Internal Medicine, James A. Haley Veterans Hospital, Tampa, Florida, USA.
Transplantation
|June 15, 1996
Summary
Organ transplant recipients on immunosuppressive therapy face a higher risk of developing cancers. This case highlights a patient with multiple, distinct cancers, underscoring the pro-malignancy environment post-transplantation.
Area of Science:
- Oncology
- Transplant Surgery
- Immunology
Background:
- Organ transplantation requires immunosuppressive therapy to prevent rejection.
- Immunosuppression is a known risk factor for increased cancer incidence.
- Post-transplant malignancy is a significant concern in long-term survivors.